Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 10 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 1

3(37.5%)

Phase 2

1(12.5%)

8Total

N/A(4)

Phase 1(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT07354282Completed

Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

Role: collaborator

NCT06398236Not ApplicableCompleted

Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms

Role: collaborator

NCT06480968Phase 1Completed

CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

Role: collaborator

NCT04199078Not ApplicableCompleted

Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.

Role: collaborator

NCT05700344Completed

SOGUG-AVELUMAB_RWD

Role: collaborator

NCT05430412Not ApplicableUnknown

CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis

Role: collaborator

NCT05218603Unknown

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Role: collaborator

NCT05060627Phase 1Recruiting

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Role: collaborator

NCT04199260Completed

Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.

Role: collaborator

NCT04196764Completed

Prospective Observational Study of Pain Evolution in Patients With Primary Knee Osteoarthritis Treated With Pronolis® HD

Role: collaborator

NCT04002154Not ApplicableCompleted

Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV

Role: collaborator

NCT02636010Phase 2Completed

Pembrolizumab (MK-3475) in MM Patients With Residual Disease

Role: collaborator

NCT01529320Phase 1Completed

Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers

Role: collaborator

All 13 trials loaded